Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review
Transgender and gender-diverse (TGD) individuals face an elevated risk of cancer in comparison with the general population. This increased risk is primarily attributed to an imbalanced exposure to modifiable risk factors and a limited adherence to cancer screening programmes, stemming from historica...
Saved in:
Main Authors: | Matteo Lambertini, Filippo Pietrantonio, Dario Trapani, Francesco Perrone, Rossana Berardi, Saverio Cinieri, Chiara Cassani, Amelia Barcellini, Filippo Ghelardi, Alberto Giovanni Leone, Stefania Bonadonna, Marianna Sirico, Barbara Tagliaferri, Stefano Maccarone, Davide Dalu, Lorenzo Ruggieri, Simone Nardin, Nicla La Verde |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-07-01
|
Series: | BMJ Oncology |
Online Access: | https://bmjoncology.bmj.com/content/3/1/e000330.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The AFFIRM Framework for gender-affirming care: qualitative findings from the Transgender and Gender Diverse Health Equity Study
by: Meg Quint, et al.
Published: (2025-02-01) -
Gender Affirmation Surgery: Financial Considerations
by: Chloe W. Swearingen, et al.
Published: (2020-12-01) -
Gender Affirmation Surgery: Financial Considerations
by: Chloe W. Swearingen, et al.
Published: (2020-12-01) -
The genetics and hormonal basis of human gender identity
by: Rafael Loch Batista, et al.
Published: (2025-01-01) -
Gender and Health in Asia: Toward Gender-Affirming Care in the ASEAN Region
by: Rowalt Alibudbud
Published: (2025-01-01)